Dissection of two routes to naïve pluripotency using different kinase inhibitors

Ana Martinez-Val1,2, Cian J Lynch3, Isabel Calvo3

  • 1Proteomics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

Nature Communications
|March 26, 2021
PubMed

Insights

Two small molecule inhibitors, 2i and Cdk8/19i, maintain embryonic stem cells (ESCs) in a naïve state. Both treatments reveal overlapping molecular events, supporting naive cell mitochondrial capacity via post-transcriptional de-repression.

Area of Science:

  • Stem cell biology
  • Molecular and Cellular Biology

Background:

  • Embryonic stem cells (ESCs) can be maintained in a pluripotent naïve state using specific inhibitors.
  • The 2i inhibitor cocktail (Mek1/2 and Gsk3 inhibitors) and Cdk8/19 inhibition (Cdk8/19i) are known to stabilize this naïve state.

Purpose of the Study:

  • To comprehensively analyze the molecular events (phosphoproteome, proteome, metabolome) induced by 2i and Cdk8/19i in ESCs.
  • To compare the overlapping and distinct mechanisms employed by 2i and Cdk8/19i in maintaining ESC naïve pluripotency.

Main Methods:

  • Mass spectrometry-based phosphoproteomics, proteomics, and metabolomics were employed.
  • Comparative analysis of molecular profiles under 2i and Cdk8/19i treatments.

Main Results:

  • Both 2i and Cdk8/19i treatments exhibit significant molecular commonalities, suggesting overlapping pathways.
  • Post-transcriptional de-repression by both inhibitors appears to enhance mitochondrial capacity in naïve ESCs.
  • Distinct proteome reprogramming mechanisms were observed: Cdk8/19i directly activates transcription, while 2i stabilizes via de-phosphorylation.

Conclusions:

  • 2i and Cdk8/19i share common downstream effects in maintaining the naïve ESC state, particularly in supporting mitochondrial function.
  • The study highlights divergent upstream mechanisms by which these inhibitors achieve proteome reprogramming and naïve pluripotency maintenance.